MetLife Investment Management’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,243
| Closed | -$554K | – | 2811 |
|
|
2024
Q4 | $554K | Buy |
52,243
+2,933
| +6% | +$31.1K | ﹤0.01% | 1744 |
|
|
2024
Q3 | $651K | Hold |
49,310
| – | – | ﹤0.01% | 1637 |
|
|
2024
Q2 | $485K | Buy |
49,310
+40,823
| +481% | +$401K | ﹤0.01% | 1729 |
|
|
2024
Q1 | $117K | Hold |
8,487
| – | – | ﹤0.01% | 2465 |
|
|
2023
Q4 | $145K | Buy |
+8,487
| New | +$145K | ﹤0.01% | 2414 |
|